Specifically speaking, when MTB infects the human body, it triggers both innate and adaptive immune responses, and CD4+ T cells, a subset of T lymphocytes, are crucial in TB immunomodulation (Zhuang et al., 2023; Li et al., 2023; Jiang et al., 2023). The gene discussed is CD4; the disease is tuberculosis.